Max Higgins, Senior Consultant, Author at EverGlade - Page 8 of 12

Max Higgins, Senior Consultant

Max Higgins, Senior Consultant
Transparent ampules on a blue background

BARDA’s Call to Action Antibiotics for Treatment of Bacterial Pneumonia or Bloodstream Infections

Combating Resistant Infections: BARDA’s Push for Advanced Antibiotics The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), has released a pre-solicitation notice aimed at identifying qualified vendors to support the late-stage development, procurement, and stockpiling of antibiotics for critical public health threats. Targeted programs include […]

BARDA’s Call to Action Antibiotics for Treatment of Bacterial Pneumonia or Bloodstream Infections Read More »

Vaccine Development

BARDA’s Call to Action on Marburg and Sudan Virus Vaccines

Preparing for the Next Biological Threat: BARDA’s Vaccine Initiative for MARV and SUDV The Biomedical Advanced Research and Development Authority (BARDA), operating under the U.S. Department of Health and Human Services (HHS), has issued a pre-solicitation notice signaling its intent to launch a major Request for Proposal (RFP) later this year. This effort, managed by

BARDA’s Call to Action on Marburg and Sudan Virus Vaccines Read More »

Medicine manufacturing assembly line.

ARPA-H’s Scalable Solutions ISO

Mission Office Innovative Solutions Opening (ISO)– ARPA-H-SOL-24-105 – Amendment 03: October 14, 2025 The Advanced Research Projects Agency for Health (ARPA-H) officially released solicitation ARPA-H-SOL-24-105 under its Scalable Solutions Office (SSO), titled Mission Office Innovative Solutions Opening (ISO). This initiative aims to fuel bold, high-impact biomedical and health innovations that tackle persistent barriers in health

ARPA-H’s Scalable Solutions ISO Read More »

Medicine production on conveyor belt

IBMSC RISE OTA Consortium RFI

Request for Information – IBMSC Resilient Industry and Supply Chain Enterprise (RISE) OTA Consortium In June 2025, the U.S. Department of Health and Human Services (HHS) issued a Request for Information (RFI) through the Administration for Strategic Preparedness and Response’s (ASPR) Center for Industrial Base Management and Supply Chain (IBMSC). This RFI invites feedback from

IBMSC RISE OTA Consortium RFI Read More »

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations

Special Topic: Ag x BTO To defend against threats to America’s agricultural infrastructure, the Defense Advanced Research Projects Agency (DARPA) has launched a new Special Topic Area (STA) through its Biological Technologies Office (BTO). Known as Ag x BTO, this initiative seeks to catalyze innovative approaches to defending the U.S. agricultural system from chemical, biological,

DARPA’s Ag x BTO Special Topic Calls for Agricultural Defense Innovations Read More »

Doctor holding augmented reality medical-related digital icons

ARPA-H Resilient Systems ISO

RESILIENT SYSTEMS OFFICE – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) – ARPA-H-SOL-24-103 – Amendment 03: October 14, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Innovative Solutions Opening (ISO) under the Resilient Systems Office (RSO), under Solicitation Number ARPA-H-SOL-24-103. a mission-focused solicitation designed to confront systemic challenges across

ARPA-H Resilient Systems ISO Read More »

Digital composite image of scientific experiment and dNA strands

ARPA-H Health Science Futures ISO

Health Science Futures – MISSION OFFICE INNOVATIVE SOLUTIONS OPENING (ISO) ARPA-H-SOL-24-104 – Amendment 03: October 14, 2025 The Advanced Research Projects Agency for Health (ARPA-H) has released Amendment 02 of its Health Science Futures (HSF) Mission Office Innovative Solutions Opening (ISO), under Solicitation Number ARPA-H-SOL-24-104. As part of its mission to catalyze high-risk, high-reward research,

ARPA-H Health Science Futures ISO Read More »

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments

On June 6, 2025, the Advanced Research Projects Agency for Health (ARPA-H) issued Amendment 02 to its four flagship Innovation Solutions Opening (ISO) solicitations: Health Science Futures (HSF), Proactive Health Office (PHO), Resilient Systems Office (RSO), and Scalable Solutions Office (SSO). These ISOs represent the core operational arms of ARPA-H’s mission to fund transformative, high-risk,

ARPA-H’s Four Mission Offices Sharpen Their Vision with ISO Amendments Read More »

Vaccine Research

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA BAA-23-100-SOL-00004 – Office of Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA) In response to today’s evolving public health landscape, the Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS) within the Administration for Strategic

Strengthening National Preparedness: BARDA’s FY23 Modernized BAA Read More »

Superconductor microchip with blue overlay

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA

Broad Agency Announcement Defense Sciences Office (DSO) Office-wide BAA Defense Sciences Office HR001125S0013 Pioneering the Next Generation of Defense Research On June 3, 2025, the Defense Advanced Research Projects Agency (DARPA), through its Defense Sciences Office (DSO), announced an open solicitation under Broad Agency Announcement (BAA) HR001125S0013. This office-wide BAA serves as a mechanism for

Unlocking Scientific Breakthroughs for National Security: DARPA’s DSO Office-wide BAA Read More »

Rapid Response Test

BARDA’s DxR2 RPP: Scaling Biothreat Diagnostic Readiness

In a continued effort to bolster national preparedness against emerging biological threats, the Biomedical Advanced Research and Development Authority (BARDA) has released the Phase 2 issue of the “Biothreat Diagnostic Rapid Response” Solicitation (RPP-25-06-DxR2) on May 29, 2025, under its Rapid Response Partnership Vehicle (RRPV). BARDA is seeking to address pressing gaps in diagnostic test

BARDA’s DxR2 RPP: Scaling Biothreat Diagnostic Readiness Read More »

radiation voltaics

Rads to Watts Proposers Day

Program Overview Rads to Watts is a DARPA program dedicated to pioneering innovative methods for directly converting nuclear radiation into electricity, with a primary emphasis on radiation voltaics (also known as radiovoltaics). The program’s long-term goal is to develop radiovoltaic systems capable of transforming high-power nuclear radiation into kilowatts of electrical energy. Achieving operation at

Rads to Watts Proposers Day Read More »

Scroll to Top